Adenosine A2A antagonists with potent anti-cataleptic activity
- 23 September 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (18) , 2349-2352
- https://doi.org/10.1016/s0960-894x(97)00440-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Current Developments of A2a Adenosine Receptor AntagonistsCurrent Medicinal Chemistry, 1995
- KF17837: A novel selective adenosine A2A receptor antagonist with anticataleptic activityEuropean Journal of Pharmacology, 1994
- KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine) a potent and selective adenosine A2 receptor antagonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthineJournal of Medicinal Chemistry, 1993
- (E)-1,3-Dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonistsJournal of Medicinal Chemistry, 1992
- Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with diseaseNeuroscience, 1991
- Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680European Journal of Pharmacology, 1989
- Are methylxanthine effects due to antagonism of endogenous adenosine?Trends in Pharmacological Sciences, 1980